Mutation and expression analysis of the putative prostate tumour-suppressor gene PTEN
1998

Analysis of PTEN Gene Mutations in Prostate Cancer

Sample size: 37 publication Evidence: moderate

Author Information

Author(s): IC Gray, LMD Stewart, SMA Phillips, JA Hamilton, NE Gray, GJ Watson, NK Spurr, D Snaryl

Primary Institution: Imperial Cancer Research Fund

Hypothesis

PTEN acts as a tumour suppressor gene in prostate cancer.

Conclusion

The study found that PTEN mutations are present in a significant number of prostate tumors, supporting its role as a tumor suppressor.

Supporting Evidence

  • Five PTEN mutations were identified in 37 primary prostatic tumors analyzed.
  • 70% of tumors showed loss or alteration of at least one PTEN allele.
  • PTEN mutations have been found in various tumor types, including gliomas and melanomas.

Takeaway

Scientists looked at prostate cancer samples and found changes in a gene called PTEN that might help explain how the cancer grows.

Methodology

The study involved mutation analysis of PTEN in primary prostate tumors using PCR and sequencing.

Limitations

The number of mutations detected was lower than expected, possibly due to sequencing inefficiencies and contamination issues.

Participant Demographics

Men undergoing transurethral resection of the prostate.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication